Coronavirus Today: Can Novavax persuade holdouts to get vaccinated? - Los Angeles Times
Novavax's FDA-approved COVID vaccine is well-suited to fight Omicron BA.5 | Fortune
Novavax launches pivotal U.S. trial of dark horse COVID-19 vaccine after manufacturing delays | Science | AAAS
New Novavax Shot Could Appeal to Pro-Life Christian Skeptics | News & Reporting | Christianity Today
New Novavax COVID-19 vaccine could address inequity and demand - The Well : The Well
Novavax publishes positive initial data for first combined Covid and flu vaccine | Financial Times
FDA advisers greenlight Novavax COVID-19 vaccine | Science | AAAS
FDA advisers recommend Novavax COVID vaccine for emergency use | CIDRAP
RACGP - First safety data on Novavax released
Novavax targets May approval for COVID-19 vaccine in the U.S. | Fierce Biotech
Novavax and SII obtain WHO Emergency Use Listing for Covid-19 vaccine
Novavax, fashionably late to the COVID-19 vaccine party, could still reap $5B in 2022: analyst | Fierce Pharma
Frontiers | SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
What Happened to the Novavax Vaccine? | MedPage Today
Self-Unblinding Threatens COVID Vaccine Trial | MedPage Today
How Novavax's COVID vaccine gained a cult-like following before US approval | Fortune
mRNA vaccines ease breakthrough COVID; Novavax helps block variant | CIDRAP
